Background
The SARS-Cov-2 Omicron variant demonstrates rapid spread but with reduced
disease severity. Studies evaluating the lung imaging findings of
Omicron infection versus non-Omicron variants remain lacking.
Purpose
To compare Omicron and Delta variants of SARS-CoV-2 by their chest CT
radiological pattern, biochemical parameters, clinical severity and
hospital outcomes after adjusting for vaccination status.
Materials and Methods
Retrospective study of hospitalized adult patients rt-PCR positive for
SARS-CoV-2 with CT pulmonary angiography performed within 7 days of
admission between December 1, 2021 and January 14, 2022. Blinded
radiological analysis with multiple readers including RSNA CT
classification, chest CT severity score (CT-SS, range 0 least severe to
25 most severe) and CT imaging features including bronchial wall
thickening.
Results
106 patients (Delta n=66, Omicron n=40) were evaluated (mean age, 58
years ± 18, 58 men). In the Omicron group, 37% (15/40) of CT
pulmonary angiograms were categorized as normal compared with 15%
(10/66) in the Delta group (p=.016). Using a generalized linear model to
control for confounding variables, including vaccination status, Omicron
variant infection was associated with a CT-SS that was lower by 7.2
points compared to infection with Delta variant (β=-7.2, 95%CI:
-9.9, -4.5; p <.001). Bronchial wall thickening was more common
with Omicron than with the Delta variant (odds ratio [OR] 2.4, 95%CI:
1.01, 5.92, p=.04). Vaccination with a booster shot was associated with
a protective effect on chest infection compared with the unvaccinated
(CT-SS median 5 (IQR 0-11), CT-SS median 11 (IQR 7.5-14), respectively;
p = .03). The Delta variant was associated with a higher odds ratio of
severe disease (OR 4.6, 95%CI: 1.2, 26, p=.01) and critical care
admission (OR 7.0, 95%CI: 1.5, 66, p=.004) than the Omicron variant.
Conclusion
The SARS-COV-2 Omicron variant was associated with fewer and less severe
changes on chest CT compared with the Delta variant. Patients with
Omicron had greater frequency of bronchial wall thickening but lower
clinical severity and improved hospital outcomes than those with
Delta.